肺癌关注月:精准治疗+MDT 为肺癌患者“生命加时”|国产精品视频

  中新网广州11月8日电 (记者 蔡敏婕)11月为全球肺癌关注月。专家认为,近年来,随着国家对癌症防控的高度重视以及诊疗技术的不断进步,肺癌患者的五年生存率持续提升。同时,伴随着创新精准治疗方案,例如靶向联合治疗的出现,以及多学科协作(MDT)机制的完善,晚期肺癌患者亦可以实现“生命加时”的目标,收获优质的长生存。

  肺癌是我国发病率、死亡率最高的恶性肿瘤。《健康中国2030规划纲要》指出,到2030年要将我国总体癌症五年生存率提升至46.6%。近年来,各地积极落实综合防治措施,癌症防治体系持续完善、规范化诊疗水平稳步提升,癌症发病率和死亡率上升趋势有望得到遏制,包括肺癌在内,患者的五年生存率正逐年提升。

  随着体检的普及、检查手段的进步,越来越多的肺结节被筛查出来,但有了肺结节不等于就一定是肺癌。中国人民解放军总医院呼吸与危重症医学部胸部肿瘤科主任赵微介绍道:“患者筛查出肺结节后,就应前往医院进行进一步的科学检查,医生会根据结果给出推荐的随访频率。通过随访,可以对肺结节变化进行细微评估,并及时检出风险病灶、进行干预,提升早期发现、实现治愈的可能。”

  “早期肺癌患者通过规范治疗,五年生存率已得到显著提升。”北京协和医院胸外科主任梁乃新介绍,“外科手术仍是早期肺癌治愈的关键。随着微创技术,如胸腔镜、机器人手术的普及,手术创伤更小、恢复更快,更多早期患者获得了根治机会。当然,术后管理同样重要,包括术后辅助治疗、肺功能恢复、生活管理和规范随访,帮助患者树立积极心态,提升生活质量。”

  对于晚期、无法手术的肺癌患者,北京大学肿瘤医院肿瘤胸内一科主任医师赵军强调,“治疗目标从早期的‘治愈’转向‘延长生存、提升生活质量’,总生存期(OS)逐渐成为核心评价指标。目前,随着靶向治疗、免疫治疗、ADC药物等新型疗法不断突破疗效瓶颈,推动肺癌进入精准化、个体化治疗时代。以EGFR突变晚期非小细胞肺癌患者为例,目前已有精准靶向联合治疗方案,患者亦有望实现更长、更优质的生存。EGFR是非小细胞肺癌最常见的驱动基因,在我国,肺癌患者EGFR突变率约为50%。”

  此外,由于肺癌患者的个体化差异显著,每位患者的病情、基因特征及生活背景都不尽相同,因此,单一科室难以为患者量身定制最优方案。赵军表示:“多学科协作之精华在于诊断。通过MDT,在开启治疗前搭建桥梁,共同勾绘一个优选的治疗方案‘蓝图’,而不是等到治疗末期,届时各学科的解决方案也会相对有限。”(完)

baineizhangshoushu:shilihuifudexiwangbaineizhangshiyizhongchangjiandeyanbujibing,zhuyaobiaoxianweijingzhuangtidehunzhuo,congerdaozhishilixiajiang。suizhenianlingdezengchang,baineizhangdefashengjilvxianzhuzengjia,geihuanzhedeshenghuodailailezhuduobubian。raner,suizheyixuejishudejinbu,baineizhangshoushuyichengweiyizhonganquanqieyouxiaodezhiliaofangfa,weizhongduohuanzhetigonglezhongjianguangmingdexiwang。shouxian,baineizhangshoushudeanquanxingdedaoguangfanrenke。xianrujin,caiyongchaoshengruhuashudengweichuangshoushufangshi,shuhouhuifuqiduan,shuhoubingfazhengfashenglvdi。shoushuguochengtongchangzaijubumazuixiajinxing,huanzhezaiqingxingzhuangtaixiajieshoushoushu,shuhoubiankelijiganshoudaoshilidegaishan。zhezhongjishudejinbu,shidebaineizhangshoushubujinduilaonianhuanzheanquanyouxiao,duinianqinghuanzhedezhiliaoyezhujianchengweikeneng。qici,baineizhangshoushudeshijihebiyaoxingyuelaiyueshoudaozhongshi。danghuanzheyinbaineizhangdaozhirichangshenghuoshoudaoyanzhongyingxiangshi,jiuyingdangkaolvshoushuzhiliao。tongshi,zaoqishoushuyekenengjianshaoshuhoubingfazhengdefasheng,bingtigaozuizhongdeshijiaozhiliang。zheyiguandiandedaolebushaolinchuangyanjiudezhichi,qiangtiaolebaineizhangshoushuzaigaishanhuanzheshenghuozhiliangfangmiandezhongyaozuoyong。zuihou,huanzheduishoushudexinlizhunbeiyebukehushi。suiranshoushubenshenbijiaojiandan,danxuduohuanzheyinduishoushudekongjueryanwuzhiliao。tongguoyishengdezhuanyezhidaoyugoutong,huanzhekeyigengjiaqingchudilejieshoushudebiyaoxing、anquanxingheshuhouxiaoguo,congerjianqingxinlifudan,gengjijidimianduizhiliao。zongshangsuoshu,baineizhangshoushushiyixiangchengshueranquandeyixuejishu,nenggouyouxiao白(bai)内(nei)障(zhang)手(shou)术(shu):(:)视(shi)力(li)恢(hui)复(fu)的(de)希(xi)望(wang)白(bai)内(nei)障(zhang)是(shi)一(yi)种(zhong)常(chang)见(jian)的(de)眼(yan)部(bu)疾(ji)病(bing),(,)主(zhu)要(yao)表(biao)现(xian)为(wei)晶(jing)状(zhuang)体(ti)的(de)混(hun)浊(zhuo),(,)从(cong)而(er)导(dao)致(zhi)视(shi)力(li)下(xia)降(jiang)。(。)随(sui)着(zhe)年(nian)龄(ling)的(de)增(zeng)长(chang),(,)白(bai)内(nei)障(zhang)的(de)发(fa)生(sheng)几(ji)率(lv)显(xian)著(zhu)增(zeng)加(jia),(,)给(gei)患(huan)者(zhe)的(de)生(sheng)活(huo)带(dai)来(lai)了(le)诸(zhu)多(duo)不(bu)便(bian)。(。)然(ran)而(er),(,)随(sui)着(zhe)医(yi)学(xue)技(ji)术(shu)的(de)进(jin)步(bu),(,)白(bai)内(nei)障(zhang)手(shou)术(shu)已(yi)成(cheng)为(wei)一(yi)种(zhong)安(an)全(quan)且(qie)有(you)效(xiao)的(de)治(zhi)疗(liao)方(fang)法(fa),(,)为(wei)众(zhong)多(duo)患(huan)者(zhe)提(ti)供(gong)了(le)重(zhong)见(jian)光(guang)明(ming)的(de)希(xi)望(wang)。(。)首(shou)先(xian),(,)白(bai)内(nei)障(zhang)手(shou)术(shu)的(de)安(an)全(quan)性(xing)得(de)到(dao)广(guang)泛(fan)认(ren)可(ke)。(。)现(xian)如(ru)今(jin),(,)采(cai)用(yong)超(chao)声(sheng)乳(ru)化(hua)术(shu)等(deng)微(wei)创(chuang)手(shou)术(shu)方(fang)式(shi),(,)术(shu)后(hou)恢(hui)复(fu)期(qi)短(duan),(,)术(shu)后(hou)并(bing)发(fa)症(zheng)发(fa)生(sheng)率(lv)低(di)。(。)手(shou)术(shu)过(guo)程(cheng)通(tong)常(chang)在(zai)局(ju)部(bu)麻(ma)醉(zui)下(xia)进(jin)行(xing),(,)患(huan)者(zhe)在(zai)清(qing)醒(xing)状(zhuang)态(tai)下(xia)接(jie)受(shou)手(shou)术(shu),(,)术(shu)后(hou)便(bian)可(ke)立(li)即(ji)感(gan)受(shou)到(dao)视(shi)力(li)的(de)改(gai)善(shan)。(。)这(zhe)种(zhong)技(ji)术(shu)的(de)进(jin)步(bu),(,)使(shi)得(de)白(bai)内(nei)障(zhang)手(shou)术(shu)不(bu)仅(jin)对(dui)老(lao)年(nian)患(huan)者(zhe)安(an)全(quan)有(you)效(xiao),(,)对(dui)年(nian)轻(qing)患(huan)者(zhe)的(de)治(zhi)疗(liao)也(ye)逐(zhu)渐(jian)成(cheng)为(wei)可(ke)能(neng)。(。)其(qi)次(ci),(,)白(bai)内(nei)障(zhang)手(shou)术(shu)的(de)时(shi)机(ji)和(he)必(bi)要(yao)性(xing)越(yue)来(lai)越(yue)受(shou)到(dao)重(zhong)视(shi)。(。)当(dang)患(huan)者(zhe)因(yin)白(bai)内(nei)障(zhang)导(dao)致(zhi)日(ri)常(chang)生(sheng)活(huo)受(shou)到(dao)严(yan)重(zhong)影(ying)响(xiang)时(shi),(,)就(jiu)应(ying)当(dang)考(kao)虑(lv)手(shou)术(shu)治(zhi)疗(liao)。(。)同(tong)时(shi),(,)早(zao)期(qi)手(shou)术(shu)也(ye)可(ke)能(neng)减(jian)少(shao)术(shu)后(hou)并(bing)发(fa)症(zheng)的(de)发(fa)生(sheng),(,)并(bing)提(ti)高(gao)最(zui)终(zhong)的(de)视(shi)觉(jiao)质(zhi)量(liang)。(。)这(zhe)一(yi)观(guan)点(dian)得(de)到(dao)了(le)不(bu)少(shao)临(lin)床(chuang)研(yan)究(jiu)的(de)支(zhi)持(chi),(,)强(qiang)调(tiao)了(le)白(bai)内(nei)障(zhang)手(shou)术(shu)在(zai)改(gai)善(shan)患(huan)者(zhe)生(sheng)活(huo)质(zhi)量(liang)方(fang)面(mian)的(de)重(zhong)要(yao)作(zuo)用(yong)。(。)最(zui)后(hou),(,)患(huan)者(zhe)对(dui)手(shou)术(shu)的(de)心(xin)理(li)准(zhun)备(bei)也(ye)不(bu)可(ke)忽(hu)视(shi)。(。)虽(sui)然(ran)手(shou)术(shu)本(ben)身(shen)比(bi)较(jiao)简(jian)单(dan),(,)但(dan)许(xu)多(duo)患(huan)者(zhe)因(yin)对(dui)手(shou)术(shu)的(de)恐(kong)惧(ju)而(er)延(yan)误(wu)治(zhi)疗(liao)。(。)通(tong)过(guo)医(yi)生(sheng)的(de)专(zhuan)业(ye)指(zhi)导(dao)与(yu)沟(gou)通(tong),(,)患(huan)者(zhe)可(ke)以(yi)更(geng)加(jia)清(qing)楚(chu)地(di)了(le)解(jie)手(shou)术(shu)的(de)必(bi)要(yao)性(xing)、(、)安(an)全(quan)性(xing)和(he)术(shu)后(hou)效(xiao)果(guo),(,)从(cong)而(er)减(jian)轻(qing)心(xin)理(li)负(fu)担(dan),(,)更(geng)积(ji)极(ji)地(di)面(mian)对(dui)治(zhi)疗(liao)。(。)综(zong)上(shang)所(suo)述(shu),(,)白(bai)内(nei)障(zhang)手(shou)术(shu)是(shi)一(yi)项(xiang)成(cheng)熟(shu)而(er)安(an)全(quan)的(de)医(yi)学(xue)技(ji)术(shu),(,)能(neng)够(gou)有(you)效(xiao)

发布于:北京市